https://www.selleckchem.com/products/mk-4827.html
6%) were observed by CEUS only. A high correlation was found between the modalities for the number of fibroids identified per patient (r = 0.97; P .001). There was also no significant difference between the modalities for each patient in the fibroid number, size, location, or enhancement. These findings suggest that transabdominal CEUS may represent an alternative to MR in pretreatment evaluation of uterine fibroids and could serve as a test of choice in patients with a contraindication to MR. These findings suggest that transabdom